{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:08Z","timestamp":1786437008411,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,16]]},"abstract":"<jats:p>May measurement month (MMM) is a global blood pressure (BP) screening campaign that aims to emphasize the importance of BP measurement and identify those who require intervention\/follow-up for elevated BP. The objective of this regional analysis in Newfoundland and Labrador (NL), Canada, was to examine the proportion of individuals screened with elevated BP, including those with and without a history of hypertension (HTN). This cross-sectional study was completed in accordance with the global MMM protocol. All consenting adults \u226518 years old were eligible to take part. Data collection took place in 28 community pharmacies across the province of NL. Descriptive statistics were analyzed and associations between elevated BP and covariates of interest were determined using logistic regression. A total of 384 participants took part in this study, with a mean age of 54.4 years (standard deviation 18.2); 66.1% (n\u2005=\u2005254) of participants were female and 41.4% (n\u2005=\u2005159) had known HTN. A complete set of 3 BP readings were recorded for a total of 375 participants and therefore, these participants were included in the analysis. Elevated BP was observed in 21.9% (n\u2005=\u200582) of participants, including 13.5% of those who had no history of HTN (i.e., 30 of 222). Known HTN and diabetes were statistically significant predictors of elevated BP in the multivariate regression model. Regional implementation of the MMM campaign in NL helped to identify a relatively large proportion of individuals with elevated BP, including those with no history of HTN. Targeted measures are needed to achieve BP targets among individuals with hypertension and diabetes in the province.<\/jats:p>","DOI":"10.1097\/md.0000000000042522","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:01:00Z","timestamp":1747836060000},"page":"e42522","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Insights from the 2023 May measurement month campaign in Newfoundland and Labrador, Canada: A cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"given":"Stephen D.","family":"Coombs","sequence":"first","affiliation":[{"name":"Memorial University School of Pharmacy, St. John\u2019s, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross T.","family":"Tsuyuki","sequence":"additional","affiliation":[{"name":"University of Alberta Faculty of Medicine and Dentistry, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie W.","family":"Young","sequence":"additional","affiliation":[{"name":"Memorial University School of Pharmacy, St. John\u2019s, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[{"name":"Imperial College London National Heart and Lung and School of Public Health, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-2186","authenticated-orcid":false,"given":"Tiffany A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Memorial University School of Pharmacy, St. John\u2019s, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260811","article-title":"Canadian Chronic Disease Surveillance System (CCDSS)."},{"key":"R2-20260811","article-title":"Health."},{"key":"R3-20260811","article-title":"Our Province. Our Health. Our Future. A 10-Year Health Transformation: The Report.","year":"2022"},{"key":"R4-20260811","article-title":"Howe Institute commentary no. 673: troubling diagnosis: comparing Canada\u2019s Healthcare with Its International Peers.","author":"Zhang","year":"2025"},{"key":"R5-20260811","article-title":"Global report on hypertension: the race against a silent killer.","year":"2023"},{"key":"R6-20260811","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115\u2005mm\u2005Hg, 1990\u20132015.","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"R8-20260811","first-page":"886","article-title":"The estimated impact of changes in population hypertension control on cardiovascular disease in Canada from 2000 to 2017.","volume":"39","author":"Campbell","year":"2023","journal-title":"Can J Cardiol"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"E854","DOI":"10.1503\/cmaj.210140","article-title":"Refocusing on hypertension control in Canada.","volume":"193","author":"Leung","year":"2021","journal-title":"CMAJ"},{"key":"R10-20260811","article-title":"Health professionals concerned about blood pressure in Canada.","year":"2022"},{"key":"R11-20260811","article-title":"An overview of weight and height measurements on World Obesity Day.","year":"2024"},{"key":"R12-20260811","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cjco.2023.12.012","article-title":"Community pharmacy-based blood pressure screening in Newfoundland and Labrador, Canada for World Hypertension Day 2022: a cross-sectional study.","volume":"6","author":"Lee","year":"2023","journal-title":"CJC Open"},{"key":"R13-20260811","article-title":"Canadian Health Measures Survey (CHMS): detailed information for November 2022 to September 2024 (Cycle 7)."},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.120.14874","article-title":"May measurement month 2019: the global blood pressure screening campaign of the international society of hypertension.","volume":"76","author":"Beaney","year":"2020","journal-title":"Hypertension"},{"issue":"Suppl F","key":"R15-20260811","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1093\/eurheartjsupp\/suac045","article-title":"May measurement month: results of 12 national blood pressure screening programmes between 2017 and 2019.","volume":"24","author":"Poulter","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"R16-20260811","article-title":"Guideline for the pharmacological treatment of hypertension in adults.","year":"2021"},{"key":"R17-20260811","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","article-title":"A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the lancet commission on hypertension.","volume":"388","author":"Olsen","year":"2016","journal-title":"Lancet"},{"key":"R18-20260811","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5334\/gh.1066","article-title":"World heart federation roadmap for hypertension\u2014a 2021 update.","volume":"16","author":"Jeemon","year":"2021","journal-title":"Glob Heart"},{"key":"R19-20260811","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/jch.13741","article-title":"S\u00e3o Paulo call to action for the prevention and control of high blood pressure: 2020.","volume":"21","author":"Campbell","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R20-20260811","first-page":"596","article-title":"Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children.","volume":"36","author":"Rabi","year":"2020","journal-title":"Can J Cardiol"},{"key":"R21-20260811","article-title":"Standards of practice: prescribing by pharmacists.","year":"2023"},{"key":"R22-20260811","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/17151635241310878","article-title":"Community pharmacy-based hypertension screening: may measurement month 2023 in 3 Canadian provinces.","volume":"158","author":"Gysel","year":"2025","journal-title":"Can Pharm J (Ott)"},{"key":"R23-20260811","article-title":"NHS community pharmacy blood pressure check service.","year":"2022"},{"key":"R24-20260811","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension.","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"R25-20260811","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08037051.2022.2086531","article-title":"High blood pressure screening in pharmacies during may measurement month campaigns in Switzerland.","volume":"31","author":"Damianaki","year":"2022","journal-title":"Blood Press"},{"key":"R26-20260811","article-title":"Annual report 2024.","year":"2024"},{"issue":"Suppl 1","key":"R27-20260811","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.jcjd.2017.10.024","article-title":"Cardiovascular protection in people with diabetes.","volume":"42","author":"Stone","year":"2018","journal-title":"Can J Diabetes"},{"key":"R28-20260811","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/mono.12296","article-title":"II. More than just convenient: the scientific merits of homogenous convenience samples.","volume":"82","author":"Jager","year":"2017","journal-title":"Monogr Soc Res Child Dev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:00:32Z","timestamp":1786435232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":28,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042522","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}